ReviewArchives of disease in childhood2003

The potential of recombinant surfactant protein D therapy to reduce inflammation in neonatal chronic lung disease, cystic fibrosis, and emphysema.

H Clark et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.